<DOC>
	<DOCNO>NCT01798017</DOCNO>
	<brief_summary>This open-label study conduct determine whether mifepristone-misoprostol regimen uterine evacuation consist 200 mg mifepristone follow 24 hour later 800 mcg buccal misoprostol acceptable woman provider feasible introduction public sector facility Bangladesh . It also determine feasibility woman avail option take dose misoprostol outside facility .</brief_summary>
	<brief_title>Introducing Mifepristone-Misoprostol Menstrual Regulation Public Sector Facilities Bangladesh</brief_title>
	<detailed_description>This open-label study conduct determine whether mifepristone-misoprostol regimen uterine evacuation consist 200 mg mifepristone follow 24 hour later 800 mcg buccal misoprostol acceptable woman provider feasible introduction public sector facility Bangladesh . It also determine feasibility woman avail option take dose misoprostol outside facility . The specific aim project follow : - Assess whether uterine evacuation regimen allow woman option take misoprostol outside facility consist 200 mg mifepristone follow 24 hour later 800 mcg buccal misoprostol feasible introduction range clinical setting government facility Bangladesh ; - Determine whether mifepristone-misoprostol regimen uterine evacuation acceptable woman provider ; - Determine proportion woman , offer choice , would prefer take misoprostol facility proportion would prefer take outside facility .</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Be willing able sign consent form ; Be eligible menstrual regulation ( MR ) service accord clinician 's assessment ; Be willing undergo surgical evacuation necessary ; Be willing provide urine sample prior administration mifepristone Have ready easy access telephone Agree comply study procedure visit schedule â€¢ Confirmed suspect ectopic pregnancy undiagnosed adnexal mass ; Chronic renal failure ; Concurrent longterm corticosteroid therapy ; History allergy mifepristone , misoprostol prostaglandin ; Hemorrhagic disorder concurrent anticoagulant therapy ; Inherited porphyria ; Other serious physical mental health condition .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>menstrual regulation</keyword>
	<keyword>mifepristone</keyword>
	<keyword>misoprostol</keyword>
</DOC>